The IFAPP-Kings College Medical Affairs in Medicines Development Certification
Program Details

There is a growing relevance of the Medical Affairs function within pharmaceuticals and a large percentage of physicians and other biomedical professionals have no formal training in medicines development and their integration into the healthcare systems.

This program is a unique partnership between academia, industry, and professional associations aimed to foster competencies and improve performance in medical affairs and medicines development. It is anchored by a strategic collaboration between IFAPP (International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine) and King’s College London, one of the world’s leading research and teaching universities based in the heart of London.

  • The program is also sponsored by Pfizer, Sanofi, Novartis, and other major pharmaceutical companies.
  • Professional Certification granted by IFAPP and King’s College London for those completing the program.
  • Affordable tuition fees

Click here to view and download the program brochure.

Modules Include:

Module

Coordinator

Introduction to Medical Affairs in Medicines DevelopmentCoordinated by Honorio Silva, MD and Dominique Dubois, MD
Medical Affairs and Health EconomicsCoordinated by Pol Vandenbroucke, MD and Nikolas Karkanias, PhD
Drug Discovery, Exploratory and Confirmatory DevelopmentCoordinated by Sandor Kerpel-Fronius, MD and Domenico Criscuolo, MD
Clinical trials: from concept to study reportCoordinated by Domenico Criscuolo, MD and Sandor Kerpel-Fronius, MD
Regulatory Affairs, Drug Safety and PharmacovigilanceCoordinated by Xavier Luria, MD and Beate Schmidt, PhD
Medical Affairs as a Strategic Business Partner: Adding Value, Accelerating Performance, and Increasing RelevanceCoordinated by Pravin Chopra, MD and Gustavo Kesselring, MD